Article
Author(s):
An agreement reached by both VISX and Nidek aims to resolve all litigation between the parties worldwide, including patent and antitrust lawsuits in the United States.
Myopia onset predicted by accelerated eye changes a year in advance
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Economic burden of late-stage age-related macular degeneration
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Prevent Blindness declares April as Women’s Eye Health and Safety Month
OKYO Pharma releases positive long-term stability data for urcosimod in neuropathic corneal pain